Table 5.
Item | Treatment group | SED | P‐valuea | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
LOW CON | LOW STEP | HIGH CON | HIGH STEP | Exercb | BCSc | Exerc × BCS | Exerc × time | BCS × time | Exerc × BCS ×time | ||
(n = 7) | (n = 7) | (n = 8) | (n = 8) | ||||||||
NEFA (mmol/L) | 0.33 | 0.34 | 0.53 | 0.45 | 0.086 | 0.535 | 0.018 | 0.474 | 0.909 | 0.206 | 0.888 |
BHB (mmol/L) | 0.69 | 0.59 | 0.84 | 0.72 | 0.096 | 0.009 | 0.127 | 0.493 | 0.891 | 0.477 | 0.500 |
Cholesterol (mmol/L) | 2.94 | 2.94 | 3.01 | 2.70 | 0.280 | 0.416 | 0.440 | 0.460 | 0.039 | 0.272 | 0.498 |
HDL‐chol (mmol/L) | 2.08 | 2.07 | 2.12 | 1.93 | 0.181 | 0.586 | 0.650 | 0.912 | 0.059 | 0.196 | 0.713 |
LDL‐chol (mmol/L) | 0.84 | 0.85 | 0.86 | 0.72 | 0.104 | 0.504 | 0.142 | 0.372 | 0.397 | 0.813 | 0.548 |
VLDL‐chol (mmol/L) | 0.02 | 0.02 | 0.04 | 0.04 | 0.007 | 0.957 | 0.001 | 0.802 | 0.808 | 0.744 | 0.339 |
(n = 4) | (n = 4) | (n = 4) | (n = 4) | ||||||||
Liver TG (g/kg ww) | 17 | 21 | 53 | 36 | 10.3 | 0.499 | 0.005 | 0.160 | 0.137 | 0.007 | 0.331 |
Liver TG (relative) | 1.8 | 1.7 | 3.9 | 2.3 | 0.71 | 0.099 | 0.058 | 0.229 | 0.202 | 0.043 | 0.359 |
Abbreviations: Exerc, exercise group (CON vs. STEP); BCS, body condition score class (LOW vs. HIGH).
The main effect “time of sampling” was significant for all parameters reported (p < .001), except for BHB (tendency, p = .089) and VLDL‐chol (p = .235).
The significance value was set at p < .05, and a trend was declared at 0.05 ≤ p < .10.